Literature DB >> 17448923

Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation.

Aarthi Shenoy, Bipin N Savani, A John Barrett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17448923     DOI： 10.1016/j.bbmt.2007.01.070

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  4 in total

1.  Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias.

Authors:  Gülsüm Emel Pamuk; Murat Taşçi; Erman Oztürk; Muzaffer Demir
Journal:  Med Oncol       Date:  2009-01-10       Impact factor: 3.064

2.  Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis.

Authors:  Dania Khoulani; Bharat Rao; Ammar Khanshour; Philip Kuriakose; Lenar Yessayan
Journal:  Case Rep Hematol       Date:  2014-07-10

Review 3.  Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis.

Authors:  Jeong A Park
Journal:  Int J Mol Sci       Date:  2021-01-14       Impact factor: 5.923

4.  In vitro characterization of CT-001-a short-acting factor VIIa with enhanced prohemostatic activity.

Authors:  Derek S Sim; Cornell R Mallari; John M Teare; Richard I Feldman; Maxine Bauzon; Terry W Hermiston
Journal:  Res Pract Thromb Haemost       Date:  2021-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.